Table 3.
Combined models of SBP and RHR for all-cause mortality; N = 2013, 165 deaths | ||||
---|---|---|---|---|
Baseline SBP (per 10 mmHg increase) | Baseline RHR (per 10 bpm increase) | |||
HR (95% CI) | p -Value | HR (95% CI) | p -Value | |
Model 1. + Age, Sex, BMI, Diabetes, CAD, PH, AF, NYHAc, eGFR | 0.89 (0.826–0.958) | 0.002 | 1.09 (1.018–1.171) | 0.014 |
Model 2. Model 1 + Severe TR, LVEF, LVEDDi | 0.90 (0.833–0.969) | 0.005 | 1.09 (1.013–1.170) | 0.020 |
Model 3. Model 1 + β blocker, Diuretic | 0.89 (0.822–0.955) | 0.002 | 1.08 (1.007–1.160) | 0.031 |
Model 4. Model 1 + Hb, Alb, Tbil | 0.91 (0.841–0.975) | 0.009 | 1.10 (1.023–1.180) | 0.010 |
Model 5. Model 1 + Etiology | 0.86 (0.792–0.934) | <0.001 | 1.11 (1.033–1.202) | 0.005 |
Combined models of DBP and RHR for all-cause mortality; N = 2,013, 165 deaths | ||||
Baseline DBP (per 10 mmHg increase) | Baseline RHR (per 10 bpm increase) | |||
HR (95% CI) | p -Value | HR (95% CI) | p -Value | |
Model 1. + Age, Sex, BMI, Diabetes, CAD, PH, AF, NYHAc, eGFR | 0.76 (0.671–0.861) | <0.001 | 1.15 (1.070–1.232) | <0.001 |
Model 2. Model 1 + Severe TR, LVEF, LVEDDi | 0.76 (0.667–0.859) | <0.001 | 1.14 (1.064–1.230) | <0.001 |
Model 3. Model 1 + β blocker, Diuretic | 0.76 (0.672–0.860) | <0.001 | 1.14 (1.060–1.222) | <0.001 |
Model 4. Model 1 + Hb, Alb, Tbil | 0.80 (0.705–0.912) | 0.001 | 1.14 (1.062–1.227) | <0.001 |
Model 5. Model 1 + Etiology | 0.72 (0.627–0.826) | <0.001 | 1.18 (1.096–1.273) | <0.001 |
AF, atrial fibrillation; Alb, albumin; BMI, body mass index; CAD, coronary heart disease; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; LVEDDi, indexed left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; PH, pulmonary hypertension; RHR, resting heart rate; SBP, systolic blood pressure; Tbil, total bilirubin; TR, tricuspid regurgitation.